Silent Inflammatory Bowel Disease

被引:14
作者
Coates, Matthew D. [1 ,2 ]
Binion, David G. [3 ]
机构
[1] Penn State Coll Med, Div Gastroenterol & Hepatol, Dept Med, Hershey, PA USA
[2] Penn State Coll Med, Dept Pharmacol, Hershey, PA USA
[3] Univ Pittsburgh, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
关键词
silent inflammatory bowel disease; Crohn's disease; ulcerative colitis; asymptomatic active disease; visceral hypoalgesia; MAGNETIC-RESONANCE ENTEROGRAPHY; PRIMARY SCLEROSING CHOLANGITIS; C-REACTIVE PROTEIN; CROHNS-DISEASE; ULCERATIVE-COLITIS; PYOSTOMATITIS VEGETANS; NATURAL-HISTORY; RISK-FACTORS; INTESTINAL INFLAMMATION; ANKYLOSING-SPONDYLITIS;
D O I
10.1093/crocol/otab059
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel disease (IBD) is frequently associated with a variety of problematic symptoms, including abdominal pain and bowel habit changes, which are associated with poor patient quality of life and significant healthcare expenditure. Interestingly, silent IBD, a condition where patients demonstrate reduced perception and/or reporting of symptoms in the setting of active inflammation, may be as clinically consequential. This condition has been associated with serious complications leading to more costly interventions. It is by its nature an under-recognized phenomenon that affects substantial portions of patients with either Crohn's disease or ulcerative colitis. At the present time, although there are a variety of theories relating to the underlying causes and contributors, little is known about why this phenomenon occurs. As a result, there is a lack of cost-effective, reliable diagnostic methods to identify and manage "at-risk" patients. However, it is significantly likely that further study and an improved understanding of this condition will lead to improved approaches for the diagnosis and treatment of patients with silent IBD as well as other gastrointestinal disorders associated with alterations in symptomatic perception. In this article, we critically review studies that have investigated silent IBD. Specifically, we discuss the following: (1) the methods for defining silent IBD, (2) the known epidemiology of silent IBD, (3) potential causes of and contributors to this clinical entity, (4) current diagnostic modalities available to identify it, and (5) gaps in our understanding as well as potential novel diagnostic and therapeutic applications that could be developed with further study of this condition. Lay Summary Silent inflammatory bowel disease is a poorly understood and impactful condition where patients with active disease exhibit minimal symptoms. Here, we review prior relevant studies and explore how more careful research could refine our understanding of this phenomenon.
引用
收藏
页数:8
相关论文
共 103 条
[1]   Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report [J].
Aberg, F. ;
Abdulle, A. ;
Makela, A. ;
Nissinen, M. .
TRANSPLANTATION PROCEEDINGS, 2015, 47 (09) :2775-2777
[2]   Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease [J].
af Bjorkesten, Clas-Goran ;
Nieminen, Urpo ;
Turunen, Ulla ;
Arkkila, Perttu ;
Sipponen, Taina ;
Farkkila, Martti .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) :528-537
[3]  
Ahmed Amany H, 2007, Exp Clin Cardiol, V12, P189
[4]  
Ahmed Waseem, 2016, Gastroenterol Hepatol (N Y), V12, P668
[5]   Diagnosis of small bowel Crohn's disease:: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis [J].
Albert, JG ;
Martiny, F ;
Krummenerl, A ;
Stock, K ;
Lesske, J ;
Göbel, CM ;
Lotterer, E ;
Nietsch, HH ;
Behrmann, C ;
Fleig, WE .
GUT, 2005, 54 (12) :1721-1727
[6]   Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease [J].
Allegretti, Jessica R. ;
Borges, Lawrence ;
Lucci, Matthew ;
Chang, Matthew ;
Cao, Bonnie ;
Collins, Emily ;
Vogel, Brian ;
Arthur, Emily ;
Emmons, Danielle ;
Korzenik, Joshua R. .
INFLAMMATORY BOWEL DISEASES, 2015, 21 (11) :2583-2589
[7]   Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases [J].
Allocca, Mariangela ;
Danese, Silvio ;
Laurent, Valerie ;
Peyrin-Biroulet, Laurent .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) :1309-+
[8]  
Asghar Javariah I, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.11.2011.5265
[9]   Pyostomatitis Vegetans: A Clue for Diagnosis of Silent Crohn's Disease [J].
Atarbashi-Moghadam, Saede ;
Lotfi, Ali ;
Atarbashi-Moghadam, Fazele .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (12) :ZD12-ZD13
[10]   Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation [J].
Baars, Judith E. ;
Nuij, Veerle J. A. A. ;
Oldenburg, Bas ;
Kuipers, Ernst J. ;
van der Woude, Christien J. .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (09) :1634-1640